Skip to main content
Prakash Deedwania, MD, Cardiology, Fresno, CA, Fresno VA Medical Center

PrakashChandraDeedwaniaMDFACC, FAHA, FHFSA,FCCP, FASH, FESC

Cardiology • Fresno, CA

Heart Failure & Transplantation, Preventive Cardiology, Clinical Pharmacology

Professor, UCSF School of Medicine, SanFrancisco, CA

Join to view full profile

Dr. Deedwania is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Deedwania's full profile

Already have an account?

Education & Training

  • University of Illinois College of Medicine at Chicago
    University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1975 - 1977
  • Icahn School of Medicine at Mount Sinai (Elmhurst)
    Icahn School of Medicine at Mount Sinai (Elmhurst)Fellowship, Pulmonary Disease, 1972 - 1975
  • Maimonides Medical Center
    Maimonides Medical CenterResidency, Internal Medicine, 1971 - 1972
  • Jawaharlal Nehru Medical College
    Jawaharlal Nehru Medical CollegeClass of 1969

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1980 - 2025
  • IL State Medical License
    IL State Medical License 1975 - 1987
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease
  • American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • Fellow (FACC) American College of Cardiology

Publications & Presentations

PubMed

Journal Articles

  • Efficacy and Safety of PCSK9 Inhibition with Evolocumab in Reducing Cardiovascular Events in Patients with Metabolic Syndrome Receiving Statin Therapy  
    Prakash Deedwania, Narimon Honarpour, Marc S Sabatine, Robert P Giugliano, JAMA Cardiology

Lectures

  • How Does Ethnicity Impact Cardiometabolic Risk? 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
  • How Does Ethnicity Impact Cardiometabolic Risk? 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
  • Dangers of Hypoglycemia in Cardiac Patients with Diabetes 
    University of California, San Francisco, California City, California - 10/22/2012

Other

Authored Content

  • Efficacy and Safety of PCSK9 Inhibition with Evolocumab in Reducing Cardiovascular Events in Patients with Metabolic Syndrome Receiving Statin TherapyAugust 2020
  • Efficacy and Safety of PCSK9 Inhibition with Evolocumab in Reducing Cardiovascular Events in Patients with Metabolic Syndrome Receiving Statin TherapyAugust 2020

Press Mentions

  • As Weight-Loss Drugs Hit the U.S. Market, Doctors Debate How to Use Them
    As Weight-Loss Drugs Hit the U.S. Market, Doctors Debate How to Use ThemMarch 30th, 2023
  • US Doctor Groups Debate Best Use of New Weight-Loss Drugs
    US Doctor Groups Debate Best Use of New Weight-Loss DrugsMarch 30th, 2023
  • The Best Statins to Lower Non-HDL Cholesterol in Diabetes?
    The Best Statins to Lower Non-HDL Cholesterol in Diabetes?April 15th, 2022
  • Join now to see all

Professional Memberships

Hospital Affiliations

Dr. Prakash Deedwania, Dr. Prakash Deedwania, MD, Dr. P Deedwania, Dr. Prakash Chandra Deedwania